Case study of the morphologic variation of circulating tumor cells

被引:145
作者
Marrinucci, Dena
Bethel, Kelly
Bruce, Richard H.
Curry, Douglas N.
Hsieh, Ben
Humphrey, Mark
Krivacic, Robert T.
Kroener, Joan
Kroener, Lindsay
Ladanyi, Andras
Lazarus, Nicole H.
Nieva, Jorge
Kuhn, Peter [1 ]
机构
[1] Scripps Res Inst, Scripps PARC Inst Adv Biomed Sci, Dept Cell Biol, La Jolla, CA 92037 USA
[2] Scripps Clin, Scripps Clin Med Grp, Dept Pathol, La Jolla, CA 92037 USA
[3] Scripps Clin, Scripps Clin Med Grp, Dept Oncol, La Jolla, CA 92037 USA
[4] Palo Alto Res Ctr, Scripps PARC Inst Adv Biomed Sci, Palo Alto, CA 94304 USA
[5] Scripps Res Inst, Scripps PARC Inst Adv Biomed Sci, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
breast cancer; circulating tumor cells; cytokeratin; fiber-optic array scanning technology; metastasis; Wright-Giemsa stain;
D O I
10.1016/j.humpath.2006.08.027
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report a detailed cytomorphologic evaluation of the circulating component of widely metastatic breast carcinoma. A previously healthy 38-year-old woman was diagnosed with breast cancer. Wide local excision revealed a 1.7-cm infiltrating ductal adenocarcinoma, BSR score 7/9 with angiolymphatic invasion, and 4/20 lymph nodes positive for carcinoma. Five years later, a bone marrow biopsy revealed involvement of bone marrow by metastatic breast carcinoma, and shortly thereafter, metastases were identified in the liver and lung hilum. She enrolled in a clinical investigation for the detection of circulating tumor cells (CTCs) in breast carcinoma. A total of 659 CTCs were identified in a 10-mL blood sample using an immumofluorescent protocol targeting cytokeratins and detected using fiber-optic array scanning technology. The detected CTCs were subsequently stained with a Wright-Giemsa stain, and representative cells were evaluated in detail by light microscopy for morphologic evaluation. We find that the patient's CTCs exhibit a high degree of pleomorphism including CTCs with high and low nuclear-to-cytoplasmic ratios along with CTCs exhibiting early and late apoptotic changes. In addition, in comparison with her tumor cells in other sites, the full morphologic spectrum of cancer cells present in primary and metastatic tumor is also present in peripheral blood circulation. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:514 / 519
页数:6
相关论文
共 15 条
[1]  
[Anonymous], 2004, ATKINSON ATLAS DIAG
[2]   Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer [J].
Cristofanilli, M ;
Hayes, DF ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Reuben, JM ;
Doyle, GV ;
Matera, J ;
Allard, WJ ;
Miller, MC ;
Fritsche, HA ;
Hortobagyi, GN ;
Terstappen, LWMM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1420-1430
[3]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[4]   Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells [J].
Fehm, T ;
Solomayer, EF ;
Meng, S ;
Tucker, T ;
Lane, N ;
Wang, J ;
Gebauer, G .
CYTOTHERAPY, 2005, 7 (02) :171-185
[5]  
Fehm T, 2002, CLIN CANCER RES, V8, P2073
[6]   MODEL STUDY DETECTING BREAST-CANCER CELLS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AT FREQUENCIES AS LOW AS 10(-7) [J].
GROSS, HJ ;
VERWER, B ;
HOUCK, D ;
HOFFMAN, RA ;
RECKTENWALD, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :537-541
[7]   Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival [J].
Hayes, Daniel F. ;
Cristofanilli, Massimo ;
Budd, G. Thomas ;
Ellis, Matthew J. ;
Stopeck, Alison ;
Miller, M. Craig ;
Matera, Jeri ;
Allard, W. Jeffrey ;
Doyle, Gerald V. ;
Terstappen, Leon W. W. M. .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4218-4224
[8]   High speed detection of circulating tumor cells [J].
Hsieh, HB ;
Marrinucci, D ;
Bethel, K ;
Curry, DN ;
Humphrey, M ;
Krivacic, RT ;
Kroener, J ;
Kroener, L ;
Ladanyi, A ;
Lazarus, N ;
Kuhn, P ;
Bruce, RH ;
Nieva, J .
BIOSENSORS & BIOELECTRONICS, 2006, 21 (10) :1893-1899
[9]   Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer [J].
Klein, CA ;
Blankenstein, TJF ;
Schmidt-Kittler, O ;
Petronio, M ;
Polzer, B ;
Stoecklein, NH ;
Riethmüller, G .
LANCET, 2002, 360 (9334) :683-689
[10]   Reliable and sensitive identification of occult tumor cells using the improved rare event Imaging system [J].
Kraeft, SK ;
Ladanyi, A ;
Galiger, K ;
Herlitz, A ;
Sher, AC ;
Bergsrud, DE ;
Even, G ;
Brunelle, S ;
Harris, L ;
Salgia, R ;
Dahl, T ;
Kesterson, J ;
Chen, LB .
CLINICAL CANCER RESEARCH, 2004, 10 (09) :3020-3028